Core Viewpoint - RXO Inc (NYSE: RXO) is currently facing mixed market expectations, with various research firms adjusting their price targets and ratings, indicating potential downside from its current stock price [1][4]. Group 1: Price Targets and Ratings - Stephens has set a price target of $15 for RXO, suggesting a potential downside from the current stock price of $16 [1][4]. - The consensus rating for RXO from nineteen research firms is "Hold," with an average twelve-month target price of approximately $16.07, closely aligning with the current stock price [2][4]. - Citigroup has lowered its price target from $16 to $15 while maintaining a "neutral" rating, and Truist Financial has reduced its target from $20 to $18 but still recommends a "buy" [3]. Group 2: Stock Performance and Market Capitalization - RXO's stock price has fluctuated between $15.76 and $17.40 recently, with a one-year high of $22.17 and a low of $10.43 [3]. - The company's market capitalization is approximately $2.64 billion, with a trading volume of 2,392,948 shares on the NYSE [3].
RXO Inc (NYSE: RXO) Price Target and Analyst Ratings Update